hydroxychloroquine has been researched along with mycophenolic acid in 83 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (7.23) | 29.6817 |
| 2010's | 48 (57.83) | 24.3611 |
| 2020's | 29 (34.94) | 2.80 |
| Authors | Studies |
|---|---|
| Behnam, MA; Boldescu, V; Klein, CD; Nitsche, C | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Agard, DA; Ashworth, A; Barrio-Hernandez, I; Batra, J; Beltrao, P; Bennett, MJ; Bohn, M; Bouhaddou, M; Braberg, H; Broadhurst, DJ; Cai, Y; Cakir, M; Calviello, L; Cavero, DA; Chang, JCJ; Chorba, JS; Craik, CS; d'Enfert, C; Dai, SA; Eckhardt, M; Emerman, M; Fabius, JM; Fletcher, SJ; Floor, SN; Foussard, H; Frankel, AD; Fraser, JS; Fujimori, DG; Ganesan, SJ; García-Sastre, A; Gordon, DE; Gross, JD; Guo, JZ; Haas, K; Haas, P; Hernandez-Armenta, C; Hiatt, J; Huang, XP; Hubert, M; Hüttenhain, R; Ideker, T; Jacobson, M; Jang, GM; Jura, N; Kaake, RM; Kim, M; Kirby, IT; Klippsten, S; Koh, C; Kortemme, T; Krogan, NJ; Kuzuoglu-Ozturk, D; Li, Q; Liboy-Lugo, J; Lin, Y; Liu, X; Liu, Y; Lou, K; Lyu, J; Mac Kain, A; Malik, HS; Mathy, CJP; McGregor, MJ; Melnyk, JE; Memon, D; Meyer, B; Miorin, L; Modak, M; Moreno, E; Mukherjee, S; Naing, ZZC; Noack, J; O'Meara, MJ; O'Neal, MC; Obernier, K; Ott, M; Peng, S; Perica, T; Pilla, KB; Polacco, BJ; Rakesh, R; Rathore, U; Rezelj, VV; Richards, AL; Roesch, F; Rosenberg, OS; Rosenthal, SB; Roth, BL; Roth, TL; Ruggero, D; Safari, M; Sali, A; Saltzberg, DJ; Savar, NS; Schwartz, O; Sharp, PP; Shen, W; Shengjuler, D; Shi, Y; Shoichet, BK; Shokat, KM; Soucheray, M; Stroud, RM; Subramanian, A; Swaney, DL; Taunton, J; Tran, QD; Trenker, R; Tummino, TA; Tutuncuoglu, B; Ugur, FS; Vallet, T; Venkataramanan, S; Verba, KA; Verdin, E; Vignuzzi, M; von Zastrow, M; Wang, HY; Wankowicz, SA; Wenzell, NA; White, KM; Xu, J; Young, JM; Zhang, Z; Zhou, Y | 1 |
| Chen, J; Chen, W; Choudhry, N; Xu, D; Yang, Z; Zanin, M; Zhao, X | 1 |
| Bartosh, S; Buratti, S; Reiff, A; Spencer, CH; Szer, IS | 1 |
| Petri, M | 1 |
| Lindsley, CB; Samad, AS | 1 |
| Fine, DM; Haas, M; Kasitanon, N; Magder, LS; Petri, M | 1 |
| Brotman, DJ; Gopal, S; Pile, JC | 1 |
| Bermas, BL; Ermann, J | 1 |
| Bader-Meunier, B | 1 |
| Chew, AL; Price, V; Samrao, A | 1 |
| Cardiel, MH; Cervera, R; Doukh, N; Galarza-Maldonado, C; Kourilovitch, MR; Molineros, JE; Soroka, NF; Yagur, VY; Zurita, L | 1 |
| Diamond, B; Yildirim-Toruner, C | 1 |
| Efthimiou, P; Hersh, A; Kukar, M | 1 |
| Amoura, Z; Arnaud, L; Costedoat-Chalumeau, N; Zahr, N | 1 |
| Chakravarty, EF; Dall'era, M | 1 |
| Hong, YH; Jung, YW; Kim, HJ; Lee, CK; Oh, MJ; Yun, DY | 1 |
| Audia, S; Berthier, S; Bonnotte, B; Janikashvili, N; Leguy, V; Lorcerie, B; Martin, L; Samson, M | 1 |
| Miller, AV; Ranatunga, SK | 1 |
| Byun, HJ; Cho, KH; Lee, EB; Seo, JY | 1 |
| Carroll, C; Chan, YH; Jorizzo, J; Kannagra, A; LoSicco, K; Manabat, CG; Ng, P; Tan, A; Yosipovitch, G | 1 |
| Amoura, Z; Aringer, M; Bajema, I; Berden, JH; Bertsias, GK; Boletis, J; Boumpas, DT; Cervera, R; Doria, A; Dörner, T; Ferrario, F; Floege, J; Gordon, C; Haubitz, M; Houssiau, FA; Ioannidis, JP; Isenberg, DA; Jayne, D; Kallenberg, CG; Lightstone, L; Marks, SD; Martini, A; Moroni, G; Neumann, I; Praga, M; Schneider, M; Starra, A; Tektonidou, M; Tesar, V; van Vollenhoven, RF; Vasconcelos, C; Zakharova, H | 1 |
| Berner, R; Geiger, J; Heinzmann, A; Hufnagel, M; Meinicke, H | 1 |
| Danza, A; Khamashta, M; Ruiz-Irastorza, G | 1 |
| Ceribelli, A; Chan, EK; Dominguez-Gutierrez, PR; Reeves, WH; Satoh, M; Sobel, ES | 1 |
| Canavan, T; Doan, LT; Ricardo-Gonzalez, RR; Rosenblum, MD; Shen, G; Sidorsky, T | 1 |
| Desai, S; Korta, DZ; Patel, RR; Sanchez, MR | 1 |
| Abdel Galil, SM | 1 |
| Ausavarungnirun, R; Srisuttiyakorn, C | 1 |
| Croyle, L; Morand, EF | 1 |
| Datta, A; Fleishman, W; French, SW; Karpouzas, G; Penunuri, A; Wei, CH | 1 |
| Chang, DJ; Kan, H; Molta, C; Nagar, S; Patel, J; Wallace, DJ | 1 |
| Chen, GS; Hu, SC; Lin, CL; Lin, YC; Wang, TN; Yen, FL | 1 |
| Awdishu, L; Joy, MS | 1 |
| Amoura, Z; Cohen Aubart, F; Haroche, J; Hié, M; Maisonobe, T; Mathian, A; Pereira, PR; Viala, K | 1 |
| Mok, CC | 1 |
| Apostolopoulos, D; Morand, EF | 1 |
| Huang, L; Kuang, Y; Li, W; Pang, J; Wei, D; Yang, Y; Yin, Q; Zhang, Z | 1 |
| Davis, LS; Reimold, AM | 1 |
| Antaya, RJ; Li, AW; Stamey, CR; Subtil, A; Tomayko, MM; Weed, JG | 1 |
| Kiyani, A; Parperis, K | 1 |
| Benedetto, C; Biancone, L; Colla, L; Diena, D; Manzione, AM; Marozio, L; Rossetti, M | 1 |
| Berman, JS; Govender, P; Raghu, G | 1 |
| Gutierrez, JO; Zurita, LA; Zurita, MF | 1 |
| Karasawa, K; Moriyama, T; Nitta, K; Takabe, T; Uchida, K | 1 |
| Fernández-Codina, A; Pope, JE; Walker, KM | 1 |
| Patel, VR; Rayess, N | 1 |
| Chera, HH; Cohen, M; Ishakis, R; Ozeri, DJ; Rosen, Y | 1 |
| Yates, M | 1 |
| DeParis, SW; Joseph, SS | 1 |
| Cox, A; Heaton, V; Munro, J; Renton, WD; Samuel, C; Soh, HJ | 1 |
| Feng, JY; Guan, WZ; Li, GM; Liu, HM; Sun, L; Wu, BB; Xu, H | 1 |
| Barker, KA; Barnado, A; Chung, CP; Dickson, AL; Dupont, WD; Gandelman, JS; Khan, OA; Neal, JE; Reese, T; Shuey, MM; Stein, CM | 1 |
| Gieler, U; Husein-ElAhmed, H; Steinhoff, M | 1 |
| Amiri, N; Baldwin, C; De Vera, MA; Rebić, N; Sayre, EC; Zusman, EZ | 1 |
| Benvenuti, F; Doria, A; Gatto, M; Iaccarino, L; Larosa, M; Montesso, G; Saccon, F; Zen, M | 1 |
| Al Shehhi, MA; Al-Nokhatha, SA; Jassim, IT; Khogali, HI | 1 |
| Chao, WC; Chen, DY; Chen, HH; Chen, YM; Lai, CM; Lin, CH; Yeo, KJ | 1 |
| Bradt, AR; Fullen, DR; Goldsmith, CS; Nadelman, DA; Qvarnstrom, Y; Smith, EH; Wang, F; Zaki, SR | 1 |
| Almaani, S; Brodsky, S; Parikh, SV; Rovin, BH | 1 |
| Anders, HJ; Aringer, M; Bajema, I; Bertsias, G; Boletis, J; Boumpas, DT; Cheema, K; Fanouriakis, A; Frangou, E; Hollis, J; Houssiau, FA; Jayne, D; Karras, A; Kostopoulou, M; Marchiori, F; Marks, SD; Moroni, G; Mosca, M; Parodis, I; Praga, M; Schneider, M; Smolen, JS; Teng, YKO; Tesar, V; Trachana, M; van Leew, B; van Vollenhoven, RF; Voskuyl, AE | 1 |
| Cravedi, P; Degli Antoni, A; Delsante, M; Fiaccadori, E; Gandolfini, I; Maggiore, U; Manenti, L; Peruzzi, L; Riella, LV; Zaza, G | 1 |
| Arthur, M; Cardones, AR; Femia, A; Fernandez, AP; Fett, NM; Florez-Pollack, S; Gaffney, R; Houser, J; Jacobe, H; Knabel, D; Kunzler, E; Latour, E; Laumann, A; Leung, N; Lo, K; Pappas-Taffer, LK; Prasad, S; Sharma, S; Stern, MJ; Tkachenko, E; Vleugels, RA; Yu, JM; Zhao, J | 1 |
| Mostafa, N; Phan, K; Smith, S | 1 |
| Biglia, A; Bozzalla Cassione, E; Cavagna, L; Codullo, V; Montecucco, C; Zanframundo, G | 1 |
| Fujieda, Y | 1 |
| Gaur, P; Shukla, A | 1 |
| Aull, MJ; Craig-Schapiro, R; Dadhania, DM; Gingras, L; Hartono, C; Kapur, S; Kodiyanplakkal, RP; Lee, JB; Lee, JR; Lubetzky, M; Marku-Podvorica, J; Muthukumar, T; Saal, S; Salinas, T; Sultan, S; Suthanthiran, M | 1 |
| Cao, J; Fan, L; He, F; Hu, K; Lei, M; Luo, Q; Qin, S; Shao, X; Yang, L; Yu, N | 1 |
| Bertsias, G; Boumpas, DT; Fanouriakis, A; Tziolos, N | 1 |
| Hammad, I; Porter, TF | 1 |
| Aguado, JM; Andrés, A; Caravaca-Fontán, F; Fernández-Ruiz, M; Gutiérrez, E; López-Medrano, F; Morales, E; Praga, M; Sevillano, Á; Trujillo, H | 1 |
| Isenberg, D; Lorenzo-Vizcaya, A | 1 |
| Amabili, P; Ancion, A; Defraigne, JO; Delbouille, MH; Delvenne, P; Detry, O; Hayette, MP; Hougrand, O; Lancellotti, P; Lavigne, JP; Maquoi, I; Minga Lowampa, E; Morimont, P; Ponte, C; Sakalihasan, N; Senard, M; Szecel, D; Tchana-Sato, V; Tridetti, J; Van Den Bulck, M | 1 |
| Birring, S; Brex, P; Galloway, J; Larkin, G; Murgatroyd, F; Paolino, A; Patel, A; Sado, D; Walsh, S | 1 |
| Chang, YS; Chen, WS; Huang, YF; Lai, CC; Li, TH; Tsao, YP; Wang, WH | 1 |
| Chen, H; Dell, S; Dissanayake, D; Kwan, JYY; Laxer, RM; Liu, FF; Psarianos, P; Rey-McIntyre, K; Shum, A; Wee, WB; Yip, KW | 1 |
| Duarte-García, A; Williamson, KA; Yang, JX | 1 |
| Ali, S; Bonilla, E; El-Dokla, AM; Perl, A | 1 |
| Clemmer, JS; Hillegass, WB; Taylor, EB | 1 |
| Antoni, C; Bergner, R; Ebert, MP; Galle, PR; Hetjens, S; Qian, Y; Schlevogt, B; Schmidt, HJ; Sollors, J; Teufel, A; Weis, CA; Woerns, MA | 1 |
| Lomanto Silva, R; Magnani, JW; Sattui, SE; Swabe, GM | 1 |
28 review(s) available for hydroxychloroquine and mycophenolic acid
| Article | Year |
|---|---|
The Medicinal Chemistry of Dengue Virus.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; Dengue; Dengue Virus; Humans; Molecular Conformation; Structure-Activity Relationship | 2016 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Topics: Antiviral Agents; China; Coronavirus Protease Inhibitors; COVID-19; COVID-19 Drug Treatment; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; SARS-CoV-2; Small Molecule Libraries | 2020 |
Immunosuppressive drug use in pregnancy.
Topics: Adrenal Cortex Hormones; Azathioprine; Breast Feeding; Cyclophosphamide; Cyclosporine; Female; Fetal Diseases; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Maternal-Fetal Exchange; Mycophenolic Acid; Pregnancy; Pregnancy Complications | 2003 |
The biology behind the new therapies for SLE.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens; Autoantibodies; B-Lymphocytes; Cytokines; Humans; Hydroxychloroquine; Immunity, Cellular; Immunologic Factors; Immunosuppressive Agents; Interferon-alpha; Lupus Erythematosus, Systemic; Mycophenolic Acid; Oligonucleotides; Rituximab; Toll-Like Receptors | 2007 |
Current and novel therapeutics in the treatment of systemic lupus erythematosus.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Cyclophosphamide; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulins, Intravenous; Lupus Erythematosus, Systemic; Mycophenolic Acid; Oligonucleotides; Rituximab | 2011 |
The importance of assessing medication exposure to the definition of refractory disease in systemic lupus erythematosus.
Topics: Biomarkers, Pharmacological; Disease Progression; Drug Interactions; France; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Monitoring, Physiologic; Mycophenolic Acid; Observer Variation; Treatment Failure | 2011 |
Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies.
Topics: Abatacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Clinical Trials, Phase III as Topic; Humans; Hydroxychloroquine; Immunoconjugates; Interferon-alpha; Lupus Erythematosus, Systemic; Mycophenolic Acid; Rituximab | 2011 |
Immunotherapies in rheumatologic disorders.
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Azathioprine; Certolizumab Pegol; Colchicine; Cyclophosphamide; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoconjugates; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Mycophenolic Acid; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rheumatic Diseases; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2012 |
[Treatment of systemic lupus erythematosus: myths, certainties and doubts].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Cyclophosphamide; Enzyme Inhibitors; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Mycophenolic Acid; Prognosis; Rituximab; Treatment Outcome | 2013 |
Optimizing the use of existing therapies in lupus.
Topics: Antimetabolites, Antineoplastic; Azathioprine; Cohort Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Long-Term Care; Lupus Erythematosus, Systemic; Male; Mycophenolic Acid; Prognosis; Prospective Studies; Risk Assessment; Severity of Illness Index; Survival Rate; Treatment Outcome | 2015 |
Role of Pharmacogenomics in Kidney Disease and Injury.
Topics: Acute Kidney Injury; Azathioprine; Calcineurin Inhibitors; Cisplatin; Cyclophosphamide; Cytochrome P-450 Enzyme System; Enzymes; Glomerulonephritis; Humans; Hydroxychloroquine; Membrane Transport Proteins; Mycophenolic Acid; Pharmacogenetics; Polymorphism, Genetic; Rituximab; Tacrolimus; Tenofovir | 2016 |
Therapeutic monitoring of the immuno-modulating drugs in systemic lupus erythematosus.
Topics: Animals; Calcineurin Inhibitors; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Immunologic Factors; Lupus Erythematosus, Systemic; Monitoring, Physiologic; Mycophenolic Acid; Patient Compliance; Pharmacovigilance | 2017 |
It hasn't gone away: the problem of glucocorticoid use in lupus remains.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Azathioprine; Cardiovascular Diseases; Cataract; Cushing Syndrome; Diabetes Mellitus; Disease Progression; Evidence-Based Medicine; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mycophenolic Acid; Osteonecrosis; Osteoporotic Fractures | 2017 |
Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Azathioprine; Cyclophosphamide; Drug Discovery; Glucocorticoids; Humans; Hydroxychloroquine; Immunologic Factors; Immunosuppressive Agents; Interleukin-2; Lupus Erythematosus, Systemic; Methotrexate; Molecular Targeted Therapy; Mycophenolic Acid; Recombinant Fusion Proteins; Rituximab; Ustekinumab; Vitamin D | 2017 |
Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era.
Topics: Azathioprine; Biological Products; Calcineurin Inhibitors; Cyclophosphamide; Directive Counseling; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Mycophenolic Acid; Pregnancy; Pregnancy Complications; TOR Serine-Threonine Kinases | 2018 |
Treatment of Sarcoidosis.
Topics: Adrenal Cortex Hormones; Azathioprine; Enzyme Inhibitors; Humans; Hydroxychloroquine; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Sarcoidosis | 2018 |
Recent Advances in Treatment Strategies for Lupus Nephritis.
Topics: Antihypertensive Agents; Antirheumatic Agents; Cyclophosphamide; Drug Therapy, Combination; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Nephritis; Maintenance Chemotherapy; Mycophenolic Acid; Prednisone; Remission Induction; Rituximab; Tacrolimus | 2018 |
Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.
Topics: Antirheumatic Agents; Biological Products; Biopsy; Child, Preschool; Contracture; Edema; Hematopoietic Stem Cell Transplantation; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Janus Kinase Inhibitors; Male; Methylprednisolone; Mycophenolic Acid; Prednisolone; Protein Kinase Inhibitors; Scleroderma, Localized; Scleroderma, Systemic; Skin; Synovitis; Treatment Failure; Treatment Outcome | 2019 |
Lichen planus: a comprehensive evidence-based analysis of medical treatment.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Antifungal Agents; Calcineurin Inhibitors; Calcitriol; Cyclosporine; Dapsone; Dermatologic Agents; Enoxaparin; Evidence-Based Medicine; Humans; Hydroxychloroquine; Lichen Planus; Methotrexate; Mycophenolic Acid; Retinoids; Tacrolimus; Ultraviolet Therapy | 2019 |
Update on Lupus Nephritis: Core Curriculum 2020.
Topics: Adaptive Immunity; Adrenal Cortex Hormones; Age Distribution; Autoantibodies; Autoimmunity; Biopsy; Cyclophosphamide; Female; Humans; Hydroxychloroquine; Immunity, Innate; Immunologic Factors; Immunosuppressive Agents; Induction Chemotherapy; Kidney Failure, Chronic; Kidney Transplantation; Lupus Nephritis; Maintenance Chemotherapy; Male; Mycophenolic Acid; Pregnancy; Pregnancy Complications; Renal Dialysis; Urinalysis | 2020 |
Mycophenolate mofetil and lichen planopilaris: systematic review and meta-analysis.
Topics: Humans; Hydroxychloroquine; Immunosuppressive Agents; Lichen Planus; Mycophenolic Acid; Remission Induction | 2022 |
Diversity of neuropsychiatric manifestations in systemic lupus erythematosus.
Topics: Adrenal Cortex Hormones; Antibodies, Antinuclear; Autoantibodies; Cytokines; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mental Disorders; Mycophenolic Acid; Nervous System Diseases; Rituximab | 2020 |
Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
Topics: Adult; Anti-Bacterial Agents; Antirheumatic Agents; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Drug Combinations; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lopinavir; Lung; Lupus Erythematosus, Systemic; Moxifloxacin; Mycophenolic Acid; Pandemics; Pneumonia, Viral; Prednisone; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Ritonavir; RNA, Viral; SARS-CoV-2; Tomography, X-Ray Computed | 2020 |
Update οn the diagnosis and management of systemic lupus erythematosus.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Humanized; Autoantibodies; Azathioprine; Calcineurin Inhibitors; Cardiovascular Diseases; Cyclophosphamide; Disease Management; Female; Glucocorticoids; Heart Valve Diseases; Humans; Hydroxychloroquine; Hypertension, Pulmonary; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Lupus Vasculitis, Central Nervous System; Macrophage Activation Syndrome; Methotrexate; Mycophenolic Acid; Myocarditis; Outcome Assessment, Health Care; Pericarditis; Phenotype; Pregnancy; Pregnancy Complications; Prognosis; Purpura, Thrombocytopenic, Idiopathic; Quality of Life; Recurrence; Rituximab; Severity of Illness Index; Survival Rate; Uterine Cervical Neoplasms | 2021 |
An Update on Biologic Agents During Pregnancy.
Topics: Abnormalities, Drug-Induced; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Autoimmune Diseases; Azathioprine; Biological Products; Cyclophosphamide; Cyclosporine; Female; Fetal Growth Retardation; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Leflunomide; Methotrexate; Mycophenolic Acid; Pregnancy; Pregnancy Complications; Premature Birth; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2020 |
Invasive pulmonary aspergillosis associated with COVID-19 in a kidney transplant recipient.
Topics: Acute Kidney Injury; Administration, Inhalation; Amphotericin B; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antifungal Agents; Azithromycin; Ceftriaxone; COVID-19; Deprescriptions; Female; Glucocorticoids; Graft Rejection; Humans; Hydroxychloroquine; Hyperoxaluria, Primary; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Nitriles; Oxygen Inhalation Therapy; Prednisone; Pyridines; Renal Dialysis; SARS-CoV-2; Sputum; Tacrolimus; Tomography, X-Ray Computed; Triazoles | 2021 |
Recurrent brachial plexopathy as initial presentation of systemic lupus erythematosus: A case report and review of the literature.
Topics: Adult; Brachial Plexus Neuropathies; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Mycophenolic Acid; Peripheral Nervous System | 2022 |
1 trial(s) available for hydroxychloroquine and mycophenolic acid
| Article | Year |
|---|---|
Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Kidney Function Tests; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Mycophenolic Acid; Prednisone; Severity of Illness Index; Treatment Outcome | 2001 |
54 other study(ies) available for hydroxychloroquine and mycophenolic acid
| Article | Year |
|---|---|
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
Topics: Animals; Antiviral Agents; Betacoronavirus; Chlorocebus aethiops; Cloning, Molecular; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Evaluation, Preclinical; Drug Repositioning; HEK293 Cells; Host-Pathogen Interactions; Humans; Immunity, Innate; Mass Spectrometry; Molecular Targeted Therapy; Pandemics; Pneumonia, Viral; Protein Binding; Protein Biosynthesis; Protein Domains; Protein Interaction Mapping; Protein Interaction Maps; Receptors, sigma; SARS-CoV-2; SKP Cullin F-Box Protein Ligases; Vero Cells; Viral Proteins | 2020 |
Treatment of pulmonary hemorrhage in childhood systemic lupus erythematosus with mycophenolate mofetil.
Topics: Adolescent; Combined Modality Therapy; Disease Progression; Drug Therapy, Combination; Hemorrhage; Humans; Hydroxychloroquine; Immunosuppressive Agents; Infusions, Intravenous; Lung Diseases; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone; Mycophenolic Acid; Plasmapheresis; Prednisone; Respiration, Artificial | 2003 |
Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis.
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Clinical Trials as Topic; Cohort Studies; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Nephritis; Male; Mycophenolic Acid; Prednisone; Prognosis; Proteinuria; Remission Induction; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2006 |
Missing the forest for the trees.
Topics: Abdominal Pain; Diagnosis, Differential; Drug Therapy, Combination; Enzyme Inhibitors; Female; Glucocorticoids; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Middle Aged; Mycophenolic Acid; Prednisone | 2007 |
[Childhood onset systemic lupus erythematosus: how does it must be treated in 2010?].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Child; Evidence-Based Medicine; Humans; Hydroxychloroquine; Immunosuppressive Agents; Long-Term Care; Lupus Erythematosus, Systemic; Lupus Nephritis; Mycophenolic Acid | 2010 |
Frontal fibrosing alopecia: a clinical review of 36 patients.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Anti-Bacterial Agents; Cohort Studies; Dermatologic Agents; Doxycycline; Enzyme Inhibitors; Erythema; Eyebrows; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Mycophenolic Acid; Pruritus; Retrospective Studies; Scalp; Severity of Illness Index; Time Factors | 2010 |
The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ecuador; Humans; Hydroxychloroquine; Latin America; Lupus Erythematosus, Systemic; Mycophenolic Acid; Prednisone; Rituximab; Severity of Illness Index; Treatment Outcome | 2010 |
Rituximab and lupus interstitial lung disease: friend or foe?
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Drug Therapy, Combination; Dyspnea; Glucocorticoids; Humans; Hydroxychloroquine; Immunologic Factors; Lung Diseases, Interstitial; Lupus Erythematosus, Systemic; Male; Mycophenolic Acid; Prednisolone; Respiratory Function Tests; Rituximab; Sjogren's Syndrome; Treatment Outcome | 2011 |
A case of minimal change disease treated successfully with mycophenolate mofetil in a patient with systemic lupus erythematosus.
Topics: Antirheumatic Agents; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mycophenolic Acid; Nephrosis, Lipoid; Prednisone; Young Adult | 2011 |
Haemolytic-uraemic syndrome during severe lupus nephritis: efficacy of plasma exchange.
Topics: Acute Kidney Injury; Adult; Biopsy; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Erythrocytes, Abnormal; Female; Hemolytic-Uremic Syndrome; Humans; Hydroxychloroquine; Immunosuppressive Agents; Kidney; Lupus Nephritis; Methylprednisolone; Models, Immunological; Mycophenolic Acid; Plasma Exchange; Prednisone | 2012 |
Methimazole-induced bullous systemic lupus erythematosus: a case report.
Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Antithyroid Agents; Blister; Drug Therapy, Combination; Female; Graves Disease; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Methimazole; Mycophenolic Acid; Prednisolone; Skin | 2012 |
A comparative study of clinical characteristics, work-up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Asian People; Bone Density Conservation Agents; Calcium Compounds; Carcinoma; Dermatomyositis; Dietary Supplements; Diphosphonates; Erythema; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Nasopharyngeal Neoplasms; Oxides; Prospective Studies; Pruritus; Rituximab; Singapore; Tacrolimus; Tertiary Care Centers; United States; Vitamin D; White People | 2013 |
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.
Topics: Adult; Azathioprine; Biopsy; Child; Cyclophosphamide; Disease Management; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Evidence-Based Medicine; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Kidney; Lupus Nephritis; Male; Mycophenolic Acid; Pregnancy | 2012 |
Symptoms of shrinking lung syndrome reveal systemic lupus erythematosus in a 12-year-old girl.
Topics: Chest Pain; Child; Cyclophosphamide; Diaphragm; Dyspnea; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methylprednisolone; Mycophenolic Acid; Pleurisy; Pulmonary Atelectasis; Radiography; Syndrome; Treatment Outcome | 2013 |
Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset.
Topics: Anti-Inflammatory Agents; Biomarkers; Chemokine CCL2; Chemokine CXCL10; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Mycophenolic Acid; Prednisone; Real-Time Polymerase Chain Reaction; STAT1 Transcription Factor | 2014 |
A case of Wong-type dermatomyositis with concomitant anti-MDA5 features.
Topics: Biomarkers; Biopsy, Needle; DEAD-box RNA Helicases; Dermatomyositis; Drug Therapy, Combination; Electromyography; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; Gene Expression Regulation; Humans; Hydroxychloroquine; Immunohistochemistry; Interferon-Induced Helicase, IFIH1; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Pityriasis Rubra Pilaris; Rare Diseases; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2014 |
Papulonodular mucinosis in a patient with systemic lupus erythematosus and antiphospholipid syndrome.
Topics: Adult; Antiphospholipid Syndrome; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mucinoses; Mycophenolic Acid | 2014 |
Hydroxychloroquine-induced toxic hepatitis in a patient with systemic lupus erythematosus: a case report.
Topics: Abdomen, Acute; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Chemical and Drug Induced Liver Injury; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Mycophenolic Acid | 2015 |
Papulonodular mucinosis in a suspected systemic lupus erythematosus patient.
Topics: Diagnosis, Differential; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Leg; Lupus Erythematosus, Systemic; Middle Aged; Mucinoses; Mycophenolic Acid | 2014 |
Troxis necrosis, a novel mechanism for drug-induced hepatitis secondary to immunomodulatory therapy.
Topics: Adult; Chemical and Drug Induced Liver Injury; Enzyme Inhibitors; Humans; Hydroxychloroquine; Immunomodulation; Lupus Erythematosus, Systemic; Lymphocytes; Male; Mycophenolic Acid; Necrosis | 2015 |
Longitudinal Treatment Patterns and Associated Outcomes in Patients With Newly Diagnosed Systemic Lupus Erythematosus.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Databases, Factual; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Longitudinal Studies; Lupus Erythematosus, Systemic; Male; Managed Care Programs; Methotrexate; Middle Aged; Mycophenolic Acid; Retrospective Studies; Young Adult | 2016 |
Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
Topics: Administration, Intravenous; Administration, Oral; Adrenal Cortex Hormones; Adult; Azathioprine; Case-Control Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Herpes Zoster; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Methylprednisolone; Middle Aged; Mycophenolic Acid; Retrospective Studies; Risk Factors; Taiwan; Young Adult | 2016 |
Sjögren Sensory Neuronopathy (Sjögren Ganglionopathy): Long-Term Outcome and Treatment Response in a Series of 13 Cases.
Topics: Adrenal Cortex Hormones; Adult; Aged; Cyclophosphamide; Disability Evaluation; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Male; Middle Aged; Mycophenolic Acid; Peripheral Nervous System Diseases; Retrospective Studies; Sensory Receptor Cells; Sjogren's Syndrome; Treatment Outcome; Young Adult | 2016 |
The Impact of T Cell Vaccination in Alleviating and Regulating Systemic Lupus Erythematosus Manifestation.
Topics: Adolescent; Adult; Antibodies, Antinuclear; Autoantibodies; CD4-Positive T-Lymphocytes; Complement C3; Complement C4; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Severity of Illness Index; Treatment Outcome; Vaccination; Young Adult | 2016 |
Bullous systemic lupus erythematosus in a 6-year-old boy.
Topics: Child; Enzyme Inhibitors; Glucocorticoids; Humans; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Male; Methylprednisolone; Mycophenolic Acid; Skin; Skin Diseases, Vesiculobullous | 2017 |
Familial Mediterranean Fever Imitating Lupus Flare: A Rare Coexistence of an Autoimmune Disease With an Autoinflammatory Disease.
Topics: Adult; Antirheumatic Agents; Colchicine; Familial Mediterranean Fever; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Mutation; Mycophenolic Acid; Prednisone; Pyrin; Treatment Outcome; Tubulin Modulators | 2018 |
Sjögren's Syndrome Associated with Fanconi's Syndrome and Osteomalacia.
Topics: Adult; Antibiotics, Antineoplastic; Antirheumatic Agents; Biopsy; Drug Therapy, Combination; Fanconi Syndrome; Female; Glucocorticoids; Humans; Hydroxychloroquine; Magnetic Resonance Imaging; Mycophenolic Acid; Osteomalacia; Potassium; Prednisone; Sjogren's Syndrome; Tomography, X-Ray Computed; Vitamin D | 2018 |
Treatment Algorithms for Systemic Sclerosis According to Experts.
Topics: Algorithms; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis; Calcium Channels; Cyclophosphamide; Endothelin Receptor Antagonists; Glucocorticoids; Humans; Hydroxychloroquine; Hypertension, Pulmonary; Immunosuppressive Agents; Kidney Diseases; Lung Diseases, Interstitial; Methotrexate; Mycophenolic Acid; Phosphodiesterase 5 Inhibitors; Prostaglandins; Raynaud Disease; Rituximab; Scleroderma, Systemic | 2018 |
Bilateral Severe Decreased Vision With Normal Examination Findings.
Topics: Adult; Antibiotics, Antineoplastic; Antirheumatic Agents; Autoimmune Diseases; Cataract; Cystic Fibrosis; Electroretinography; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Mycophenolic Acid; Physical Examination; Retina; Retinal Diseases; Vision Disorders; Vision Tests; Visual Acuity | 2018 |
Lemierre's Syndrome in an Aseptic Patient with Systemic Lupus Erythematosus.
Topics: Adult; Anticoagulants; Enzyme Inhibitors; Female; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Lemierre Syndrome; Lupus Erythematosus, Systemic; Mycophenolic Acid; Tomography, X-Ray Computed | 2018 |
Commonly used medication for Lupus.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Disease Management; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Methotrexate; Mycophenolic Acid; Rituximab | 2018 |
Bilateral Sequential Acute Proptosis in a Woman With No History of Trauma.
Topics: Acute Disease; Adult; Antirheumatic Agents; Drug Therapy, Combination; Enzyme Inhibitors; Exophthalmos; Eye Pain; Female; Glucocorticoids; Humans; Hydroxychloroquine; Hypertension; Lupus Erythematosus, Systemic; Mycophenolic Acid; Opioid-Related Disorders; Prednisone; Retinal Hemorrhage; Tomography, X-Ray Computed; Visual Acuity | 2019 |
A mutation in PIK3CD gene causing pediatric systemic lupus erythematosus: A case report.
Topics: Adolescent; Antibodies, Antinuclear; Asian People; Class I Phosphatidylinositol 3-Kinases; Complement System Proteins; Enzyme Inhibitors; Epstein-Barr Virus Infections; Gain of Function Mutation; Glucocorticoids; Herpesvirus 4, Human; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Deficiency Syndromes; Lupus Erythematosus, Systemic; Male; Mycophenolic Acid; Phenotype; Prednisolone; Primary Immunodeficiency Diseases | 2019 |
Increased blood pressure visit-to-visit variability in patients with systemic lupus erythematosus: association with inflammation and comorbidity burden.
Topics: Adrenal Cortex Hormones; Adult; Blood Pressure; Case-Control Studies; Comorbidity; Cyclophosphamide; Databases, Factual; Female; Humans; Hydroxychloroquine; Hypertension; Inflammation; Logistic Models; Lupus Erythematosus, Systemic; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Risk Factors; Severity of Illness Index | 2019 |
Perinatal use and discontinuation of disease-modifying anti-rheumatic drugs and biologics in women with rheumatoid arthritis: a cohort study.
Topics: Abatacept; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Biological Products; British Columbia; Chloroquine; Cohort Studies; Cyclophosphamide; Cyclosporine; Deprescriptions; Female; Glucocorticoids; Gold Compounds; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Leflunomide; Logistic Models; Maternal Age; Methotrexate; Mycophenolic Acid; Odds Ratio; Preconception Care; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Rheumatology; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2020 |
Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission.
Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cyclosporine; Deprescriptions; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Protective Factors; Recurrence; Remission Induction; Risk Factors; Symptom Flare Up; Time Factors | 2020 |
Myocarditis as a lupus challenge: two case reports.
Topics: Adrenal Cortex Hormones; Adult; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mycophenolic Acid; Myocarditis; Treatment Outcome | 2019 |
Hydroxychloroquine may reduce risk of Pneumocystis pneumonia in lupus patients: a Nationwide, population-based case-control study.
Topics: Adult; Antifungal Agents; Antirheumatic Agents; Case-Control Studies; Female; Glucocorticoids; Humans; Hydroxychloroquine; Logistic Models; Lupus Erythematosus, Systemic; Male; Middle Aged; Mycophenolic Acid; Pneumonia, Pneumocystis; Retrospective Studies; Young Adult | 2020 |
Cutaneous microsporidiosis in an immunosuppressed patient.
Topics: Dermatomycoses; Dermatomyositis; Enzyme Inhibitors; Female; Humans; Hydroxychloroquine; Immunocompromised Host; Lung Diseases, Interstitial; Microsporidiosis; Middle Aged; Mycophenolic Acid | 2020 |
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
Topics: Antirheumatic Agents; Azathioprine; Calcineurin Inhibitors; Drug Therapy, Combination; Europe; Glomerular Filtration Rate; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Nephritis; Mycophenolic Acid; Proteinuria; Societies, Medical | 2020 |
COVID-19 in kidney transplant recipients.
Topics: Aged; Betacoronavirus; Cobicistat; Colchicine; Coronavirus Infections; COVID-19; Cytokines; Darunavir; Drug Combinations; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lopinavir; Male; Middle Aged; Mycophenolic Acid; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Tacrolimus; Transplant Recipients; Treatment Outcome | 2020 |
Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cohort Studies; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Retrospective Studies; Scleroderma, Localized; Treatment Outcome; Young Adult | 2020 |
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Laboratory Techniques; Cohort Studies; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Cyclosporine; Diarrhea; Dysgeusia; Dyspnea; Fatigue; Female; Fever; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Incidence; Intensive Care Units; Italy; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Olfaction Disorders; Pandemics; Pneumonia, Viral; Prednisone; Respiratory Distress Syndrome; SARS-CoV-2; Telemedicine | 2020 |
Hereditary C1 inhibitor deficiency associated with systemic lupus erythematosus.
Topics: Angioedemas, Hereditary; Complement C1 Inhibitor Protein; Family; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Middle Aged; Mycophenolic Acid; Phenotype; Steroids; Young Adult | 2020 |
Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center.
Topics: Adult; Aged; Aged, 80 and over; Allografts; Antimalarials; Betacoronavirus; Coronavirus Infections; COVID-19; Enzyme Inhibitors; Female; Graft Rejection; Humans; Hydroxychloroquine; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; New York City; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Transplant Recipients | 2020 |
Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom.
Topics: Adult; Antirheumatic Agents; Azathioprine; Cardiovascular Diseases; Cause of Death; Cohort Studies; Enzyme Inhibitors; Female; Humans; Hydroxychloroquine; Immunocompromised Host; Infections; Lupus Erythematosus, Systemic; Male; Middle Aged; Morbidity; Mortality, Premature; Mycophenolic Acid; Neoplasms; Retrospective Studies; Risk Factors; Rituximab; Steroids; Survival Rate; Time Factors; United Kingdom | 2021 |
Clinical course and challenging management of early COVID-19 infection after heart transplantation: case report of two patients.
Topics: Antimalarials; Antiviral Agents; Comorbidity; COVID-19; Female; Heart Transplantation; Humans; Hydroxychloroquine; Immunocompromised Host; Male; Middle Aged; Mycophenolic Acid; SARS-CoV-2; Transplant Recipients | 2021 |
Clinical phenotypes and therapeutic responses in cutaneous-predominant sarcoidosis: 6-year experience in a tertiary referral service.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Clinical Protocols; Dermatologic Agents; Female; Humans; Hydroxychloroquine; Interleukin-12; Interleukin-23; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Phenotype; Prospective Studies; Quinacrine; Referral and Consultation; Remission Induction; Sarcoidosis; Skin Diseases; Tertiary Care Centers; Tumor Necrosis Factor Inhibitors; Young Adult | 2021 |
Pneumocystis Jirovecii Pneumonia in Systemic Lupus Erythematosus: A Nationwide Cohort Study in Taiwan.
Topics: Cohort Studies; Cyclophosphamide; Humans; Hydroxychloroquine; Kidney Failure, Chronic; Lupus Erythematosus, Systemic; Male; Mycophenolic Acid; Pneumocystis carinii; Pneumonia, Pneumocystis; Prednisolone; Retrospective Studies; Risk Factors; Taiwan | 2022 |
COPA Syndrome (Ala239Pro) Presenting with Isolated Follicular Bronchiolitis in Early Childhood: Case Report.
Topics: Bronchiolitis; Child; Coatomer Protein; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Mutation, Missense; Mycophenolic Acid; Prednisolone; Syndrome | 2021 |
75-Year-Old Man With Fever and Malaise.
Topics: Acute Kidney Injury; Aged; Antirheumatic Agents; Diagnosis, Differential; Humans; Hydroxychloroquine; Immunologic Tests; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone; Mycophenolic Acid; Pleural Effusion; Prognosis; Remission Induction; Renal Dialysis | 2021 |
Antihypertensive effects of immunosuppressive therapy in autoimmune disease.
Topics: Antihypertensive Agents; Female; Humans; Hydroxychloroquine; Hypertension; Immunosuppression Therapy; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mycophenolic Acid; Retrospective Studies | 2023 |
Management of Hepatic Sarcoidosis.
Topics: Antirheumatic Agents; Azathioprine; Cyclophosphamide; Digestive System Diseases; Humans; Hydroxychloroquine; Mycophenolic Acid; Sarcoidosis | 2022 |
Association of patient copayment and medication adherence in systemic lupus erythematosus.
Topics: Adult; Aged; Azathioprine; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Medication Adherence; Methotrexate; Middle Aged; Mycophenolic Acid; Retrospective Studies | 2023 |